CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended		207 Months Ended
	Jan. 31, 2013	Jan. 31, 2012	Jan. 31, 2013	Jan. 31, 2012	Jan. 31, 2013
Revenues, net	$ 0	$ 4,958	$ 0	$ 14,889	$ 5,110,784
Cost of Goods Sold	0	3,630	0	6,892	1,620,375
Gross profit	0	1,328	0	7,997	3,490,409
Operating Expenses:
Research and development	500,482	729,166	1,153,877	2,708,668	133,129,841
Research and development - related party	0	0	0	0	220,218
Selling and marketing	0	73,397	0	149,058	9,333,214
General and administrative	790,298	984,996	2,076,934	2,406,280	149,879,090
General and administrative - related party	0	0	0	0	314,328
Total Operating Expenses	1,290,780	1,787,559	3,230,811	5,264,006	292,876,691
Operating Loss	(1,290,780)	(1,786,231)	(3,230,811)	(5,256,009)	(289,386,282)
Other Income (Expense):
Miscellaneous income	0	0	0	0	686,303
Income from assets held for investment, net (Note 11)	40,998	68,249	1,083,866	780,324	5,418,123
Interest income	82	246	307	765	7,782,200
Interest expense	(249,281)	(59,911)	(367,256)	(94,832)	(69,375,938)
Change in fair value of derivative liabilities (Note 10)	(4,142,004)	(7,341,004)	(3,783,290)	(4,212,545)	(4,499,267)	[1]
Loss on extinguishment of debt	0	0	0	0	(14,134,068)
Net Loss Before Undernoted	(5,640,985)	(9,118,651)	(6,297,184)	(8,782,297)	(363,508,929)
Minority Interest Share of Loss	0	0	0	0	3,038,185
Net Loss	(5,640,985)	(9,118,651)	(6,297,184)	(8,782,297)	(360,470,744)
Preferred Stock Dividend (Note 9)	0	0	102,297	0	3,540,517
Net Loss Available to Common Stockholders	$ (5,640,985)	$ (9,118,651)	$ (6,399,481)	$ (8,782,297)	$ (364,011,261)
Basic and Diluted Net Loss Per Common Share (see Note 8) (in dollars per share)	$ (0.01)	$ (0.03)	$ (0.02)	$ (0.03)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted (Note 8) (in shares)	386,422,031	320,557,458	375,366,195	316,950,033

[1] Includes $5,981,403 as adjustment related to the adoption of FASB ASC Topic 815 in "Cumulative from November 2, 1995 (Date of Inception) to January 31, 2013" column. See Note 11 - Derivative Warrant Liability.